Intraoperative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas: Clinical article

Journal of Neurosurgery

Volumn 115, Issue 4, 2011, Pages 740-748

  Sanai, Nader ^a   Snyder, Laura A ^a   Honea, Norissa J ^a   Coons, Stephen W ^a   Eschbacher, Jennifer M ^a   Smith, Kris A ^a   Spetzler, Robert F ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

5 aminolevulinic acid; Confocal microscopy; Extent of resection; Low grade glioma; Oncology; Tumor fluorescence

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; ARTICLE; CONFOCAL MICROSCOPY; CORRELATIONAL STUDY; DISEASE SEVERITY; FEMALE; FLUORESCENCE; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAOPERATIVE CONFOCAL MICROSCOPY; LOW GRADE GLIOMA; MAJOR CLINICAL STUDY; MALE; MICROSURGERY; NEURONAVIGATION; NEUROSURGERY; PRIORITY JOURNAL; TUMOR LOCALIZATION;

ADULT; AMINOLEVULINIC ACID; BRAIN; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; INTRAOPERATIVE PERIOD; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; NEURONAVIGATION; PHOTOSENSITIZING AGENTS;

EID: 80053392646     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2011.6.JNS11252     Document Type: Article

References (57)

1. Ahmadi R, Dictus C, Hartmann C, Zürn O, Edler L, Hartmann M, et al: Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients. Acta Neurochir (Wien) 151:1359-1365, 2009 (Erratum in Acta Neurochir (Wien) 161:1367, 2009)
2. Black PM, Alexander E III, Martin C, Moriarty T, Nabavi A, Wong TZ, et al: Craniotomy for tumor treatment in an intraoperative magnetic resonance imaging unit. Neurosurgery 45:423-433, 1999 (Pubitemid 29428657)
3. Brown PD, Maurer MJ, Rummans TA, Pollock BE, Ballman KV, Sloan JA, et al: A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery 57:495-504, 2005
4. Cavaliere R, Lopes MB, Schiff D: Low-grade gliomas: an update on pathology and therapy. Lancet Neurol 4:760-770, 2005 (Pubitemid 41457292)
5. Chaichana KL, Halthore AN, Parker SL, Olivi A, Weingart JD, Brem H, et al: Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical article. J Neurosurg 114:604-612, 2011
6. Chaichana KL, Kosztowski T, Niranjan A, Olivi A, Weingart JD, Laterra J, et al: Prognostic significance of contrastenhancing anaplastic astrocytomas in adults. Clinical article. J Neurosurg 113:286-292, 2010
7. Chang EF, Smith JS, Chang SM, Lamborn KR, Prados MD, Butowski N, et al: Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. Clinical article. J Neurosurg 109:817-824, 2008
8. Claus EB, Horlacher A, Hsu L, Schwartz RB, Dello-Iacono D, Talos F, et al: Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 103:1227-1233, 2005 (Pubitemid 40328094)
9. Coenen VA, Krings T, Weidemann J, Hans FJ, Reinacher P, Gilsbach JM, et al: Sequential visualization of brain and fiber tract deformation during intracranial surgery with threedimensional ultrasound: an approach to evaluate the effect of brain shift. Neurosurgery 56 (1 Suppl):133-141, 2005
10. Duffner F, Ritz R, Freudenstein D, Weller M, Dietz K, Wessels J: Specific intensity imaging for glioblastoma and neural cell cultures with 5-aminolevulinic acid-derived protoporphyrin IX. J Neurooncol 71:107-111, 2005 (Pubitemid 40796290)
11. El-Hateer H, Souhami L, Roberge D, Maestro RD, Leblanc R, Eldebawy E, et al: Low-grade oligodendroglioma: an indolent but incurable disease? Clinical article. J Neurosurg 111:265-271, 2009
12. Floeth FW, Sabel M, Ewelt C, Stummer W, Felsberg J, Reifenberger G, et al: Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas. Eur J Nucl Med Mol Imaging 38:731-741, 2011
13. Hall WA, Liu H, Maxwell RE, Truwit CL: Influence of 1.5-Tesla intraoperative MR imaging on surgical decision making. Acta Neurochir Suppl 85:29-37, 2003 (Pubitemid 38446148)
14. Hatiboglu MA, Weinberg JS, Suki D, Rao G, Prabhu SS, Shah K, et al: Impact of intraoperative high-field magnetic resonance imaging guidance on glioma surgery: a prospective volumetric analysis. Neurosurgery 64:1073-1081, 2009
15. Hirschberg H, Samset E, Hol PK, Tillung T, Lote K: Impact of intraoperative MRI on the surgical results for high-grade gliomas. Minim Invasive Neurosurg 48:77-84, 2005 (Pubitemid 40769552)
16. Ishihara R, Katayama Y, Watanabe T, Yoshino A, Fukushima T, Sakatani K: Quantitative spectroscopic analysis of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence intensity in diffusely infiltrating astrocytomas. Neurol Med Chir (Tokyo) 47:53-57, 2007 (Pubitemid 46355955)
17. Johannesen TB, Langmark F, Lote K: Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993. J Neurosurg 99:854-862, 2003 (Pubitemid 37314921)
18. Keles GE, Lamborn KR, Berger MS: Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 95:735-745, 2001 (Pubitemid 33043344)
19. Krishnan R, Raabe A, Hattingen E, Szelenyi A, Yahya H, Hermann E, et al: Functional magnetic resonance imaging-integrated neuronavigation: correlation between lesion-to-motor cortex distance and outcome. Neurosurgery 55:904-905, 2004
20. Kurimoto M, Hayashi N, Kamiyama H, Nagai S, Shibata T, Asahi T, et al: Impact of neuronavigation and image-guided extensive resection for adult patients with supratentorial malignant astrocytomas: a single-institution retrospective study. Minim Invasive Neurosurg 47:278-283, 2004 (Pubitemid 39612497)
21. Liao H, Noguchi M, Maruyama T, Muragaki Y, Kobayashi E, Iseki H, et al: An integrated diagnosis and therapeutic system using intra-operative 5-aminolevulinic-acid-induced fluorescence guided robotic laser ablation for precision neurosurgery. Med Image Anal [epub ahead of print], 2010
22. Mansur DB, Hekmatpanah J, Wollman R, Macdonald L, Nicholas K, Beckmann E, et al: Low grade gliomas treated with adjuvant radiation therapy in the modern imaging era. Am J Clin Oncol 23:222-226, 2000 (Pubitemid 32428022)
23. McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, et al: Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 63:700-708, 2008
24. Nabavi A, Thurm H, Zountsas B, Pietsch T, Lanfermann H, Pichlmeier U, et al: Five-aminolevulinic acid for fluorescenceguided resection of recurrent malignant gliomas: a phase II study. Neurosurgery 65:1070-1077, 2009
25. Nakamura M, Konishi N, Tsunoda S, Nakase H, Tsuzuki T, Aoki H, et al: Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults. Oncology 58:108-116, 2000 (Pubitemid 30113861)
26. Nikas DC, Hartov A, Lunn K, Rick K, Paulsen K, Roberts DW: Coregistered intraoperative ultrasonography in resection of malignant glioma. Neurosurg Focus 14(2):e6, 2003
27. Nimsky C, Fujita A, Ganslandt O, Von Keller B, Fahlbusch R: Volumetric assessment of glioma removal by intraoperative high-field magnetic resonance imaging. Neurosurgery 55:358-371, 2004
28. Pamir MN, Ozduman K, Dinçer A, Yildiz E, Peker S, Ozek MM: First intraoperative, shared-resource, ultrahigh-field 3- Tesla magnetic resonance imaging system and its application in low-grade glioma resection. Clinical article. J Neurosurg 112:57-69, 2010
29. Piepmeier JM: Current concepts in the evaluation and management of WHO grade II gliomas. J Neurooncol 92:253-259, 2009
30. Pouratian N, Asthagiri A, Jagannathan J, Shaffrey ME, Schiff D: Surgery insight: the role of surgery in the management of low-grade gliomas. Nat Clin Pract Neurol 3:628-639, 2007 (Pubitemid 350048229)
31. Reinacher PC, van Velthoven V: Intraoperative ultrasound imaging: practical applicability as a real-time navigation system. Acta Neurochir Suppl 85:89-93, 2003 (Pubitemid 38446155)
32. Reithmeier T, Krammer M, Gumprecht H, Gerstner W, Lumenta CB: Neuronavigation combined with electrophysiological monitoring for surgery of lesions in eloquent brain areas in 42 cases: a retrospective comparison of the neurological outcome and the quality of resection with a control group with similar lesions. Minim Invasive Neurosurg 46:65-71, 2003 (Pubitemid 36682210)
33. Roberts DW, Valdés PA, Harris BT, Fontaine KM, Hartov A, Fan X, et al: Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article. J Neurosurg 114:595-603, 2011
34. Sanai N, Berger MS: Glioma extent of resection and its impact on patient outcome. Neurosurgery 62:753-266, 2008
35. Sanai N, Eschbacher J, Hattendorf G, Coons SW, Preul MC, Smith KA, et al: Intraoperative confocal microscopy for brain tumors: a feasibility analysis in humans. Neurosurgery [epub ahead of print], 2011
36. Sanai N, Polley MY, Berger MS: Insular glioma resection: assessment of patient morbidity, survival, and tumor progression. Clinical article. J Neurosurg 112:1-9, 2010
37. Sankar T, Delaney PM, Ryan RW, Eschbacher J, Abdelwahab M, Nakaji P, et al: Miniaturized handheld confocal microscopy for neurosurgery: results in an experimental glioblastoma model. Neurosurgery 66:410-418, 2010
38. Schneider JP, Schulz T, Schmidt F, Dietrich J, Lieberenz S, Trantakis C, et al: Gross-total surgery of supratentorial lowgrade gliomas under intraoperative MR guidance. AJNR Am J Neuroradiol 22:89-98, 2001 (Pubitemid 32105360)
39. Senft C, Bink A, Heckelmann M, Gasser T, Seifert V: Glioma extent of resection and ultra-low-field iMRI: interim analysis of a prospective randomized trial. Acta Neurochir Suppl 109:49-53, 2011
40. Senft C, Seifert V, Hermann E, Franz K, Gasser T: Usefulness of intraoperative ultra low-field magnetic resonance imaging in glioma surgery. Neurosurgery 63 (4 Suppl 2):257-267, 2008
41. Shaw E, Arusell R, Scheithauer B, O'Fallon J, O'Neill B, Dinapoli R, et al: Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial lowgrade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 20:2267-2276, 2002 (Pubitemid 34441653)
42. Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, et al: Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26:1338-1345, 2008
43. Stark AM, Nabavi A, Mehdorn HM, Blömer U: Glioblastoma multiforme-report of 267 cases treated at a single institution. Surg Neurol 63:162-169, 2005 (Pubitemid 40174904)
44. Stockhammer F, Misch M, Horn P, Koch A, Fonyuy N, Plotkin M: Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas. Acta Neurochir (Wien) 151:1377-1383, 2009
45. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ: Fluorescence-guided surgery with 5-aminolevu linic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401, 2006
46. Stummer W, Reulen HJ, Novotny A, Stepp H, Tonn JC: Fluorescence- guided resections of malignant gliomas-an overview. Acta Neurochir Suppl 88:9-12, 2003
47. Stummer W, Stepp H, Möller G, Ehrhardt A, Leonhard M, Reulen HJ: Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue. Acta Neurochir (Wien) 140:995-1000, 1998 (Pubitemid 28508688)
48. Tonn JC, Stummer W: Fluorescence-guided resection of malignant gliomas using 5-aminolevulinic acid: practical use, risks, and pitfalls. Clin Neurosurg 55:20-26, 2008
49. Unsgaard G, Selbekk T, Brostrup Müller T, Ommedal S, Torp SH, Myhr G, et al: Ability of navigated 3D ultrasound to delineate gliomas and metastases-comparison of image interpretations with histopathology. Acta Neurochir (Wien) 147:1259-1269, 2005 (Pubitemid 41674370)
50. Ushio Y, Kochi M, Hamada J, Kai Y, Nakamura H: Effect of surgical removal on survival and quality of life in patients with supratentorial glioblastoma. Neurol Med Chir (Tokyo) 45:454-461, 2005
51. van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ: Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60:166-193, 2010
52. Warnke PC: Stereotactic volumetric resection of gliomas. Acta Neurochir Suppl 88:5-8, 2003
53. Widhalm G, Wolfsberger S, Minchev G, Woehrer A, Krssak M, Czech T, et al: 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement. Cancer 116:1545-1552, 2010
54. Willems PW, Taphoorn MJ, Burger H, Berkelbach van der Sprenkel JW, Tulleken CA: Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumors: a randomized controlled trial. J Neurosurg 104:360-368, 2006 (Pubitemid 43326841)
55. Wu JS, Zhou LF, Tang WJ, Mao Y, Hu J, Song YY, et al: Clinical evaluation and follow-up outcome of diffusion tensor imaging-based functional neuronavigation: a prospective, controlled study in patients with gliomas involving pyramidal tracts. Neurosurgery 61:935-949, 2007
56. Yeh SA, Ho JT, Lui CC, Huang YJ, Hsiung CY, Huang EY: Treatment outcomes and prognostic factors in patients with supratentorial low-grade gliomas. Br J Radiol 78:230-235, 2005
57. Yeh SA, Lee TC, Chen HJ, Lui CC, Sun LM, Wang CJ, et al: Treatment outcomes and prognostic factors of patients with supratentorial low-grade oligodendroglioma. Int J Radiat Oncol Biol Phys 54:1405-1409, 2002